Medicure Inc. (TSXV: MPH) (OTC: MCUJF), a Canada-based company focused on the development and commercialisation of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced on Thursday its financial results for the quarter ended 30 September 2022.
The firm posted net income for the quarter at CAD1.1m or CAD0.11 per share, against a net loss of CAD946,000 or CAD0.09 per share for the same period in 2021.
The company reported total net revenue of CAD5.3m during the quarter ended 30 September 2022 compared to CAD4.9m in the year-ago period.
(USD1=CAD1.33)
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva